ASTM F1905-98(2003)
Standard Practice for Selecting Tests for Determining the Propensity of Materials to Cause Immunotoxicity

Standard No.
ASTM F1905-98(2003)
Release Date
1998
Published By
American Society for Testing and Materials (ASTM)
Status
 2011-03
Latest
ASTM F1905-98(2003)
Scope

1.1 This practice covers the introduction of foreign materials into the body that may have an impact on the immune system. One possible effect is that the immune system will be depressed or certain cell types may be affected. Immunotoxicity may be determined with blood and tissue samples from the animals used in the other biocompatibility test procedures such as implantation and blood contact test protocols. It is also possible to use these techniques with blood samples from human patients in a clinical trial. Any procedures with human subjects should follow the appropriate rules of the local institutional review board and the appropriate regulatory agencies. This document may serve as an annex to Practice F748.

1.2 The material may affect the humoral immune response, the cell mediated response, or both.

1.3 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.

ASTM F1905-98(2003) Referenced Document

  • ASTM F619 Standard Practice for Extraction of Medical Plastics
  • ASTM F748 Standard Practice for Selecting Generic Biological Test Methods for Materials and Devices

ASTM F1905-98(2003) history

  • 1998 ASTM F1905-98(2003) Standard Practice for Selecting Tests for Determining the Propensity of Materials to Cause Immunotoxicity
  • 1998 ASTM F1905-98 Standard Practice for Selecting Tests for Determining the Propensity of Materials to Cause Immunotoxicity
Standard Practice for Selecting Tests for Determining the Propensity of Materials to Cause Immunotoxicity



Copyright ©2024 All Rights Reserved